EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Sulforaphane Supplementation Did Not Modulate NRF2 and NF-kB mRNA Expressions in Hemodialysis Patients

Marcia Ribeiro, Ludmila Fmf Cardozo, Bruna R Paiva, Beatriz Germer Baptista, Susane Fanton, Livia Alvarenga, Ligia Soares Lima, Isadora Britto, Lia S Nakao, Denis Fouque, Marcelo Ribeiro-Alves, Denise Mafra

Journal of Renal Nutrition · 2024-01 · 34 (1) · 68-75

DOI: 10.1053/j.jrn.2023.08.008 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Renal Nutrition, 2024-01. Verfasst von Marcia Ribeiro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Biological Sciences, Department of Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil. Hauptthemen laut MEDLINE: NF-kappa B, Renal Insufficiency, Chronic, Sulfoxides, Isothiocyanates. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with chronic kidney disease (CKD) have reduced expression of erythroid nuclear factor-related factor 2 (NRF2) and increased nuclear factor κB (NF-κB). "Food as medicine" has been proposed as an adjuvant therapeutic alternative in modulating these factors. No studies have investigated the effects of sulforaphane (SFN) in cruciferous vegetables on the expression of these genes in patients with CKD. OBJECTIVE: The study aimed to evaluate the effects of SFN on the expression of NRF2 and NF-κB in patients on hemodialysis (HD). DESIGN AND METHODS: A randomized, double-blind, crossover study was performed on 30 patients on regular HD. Fourteen patients were randomly allocated to the intervention group (1 sachet/day of 2.5 g containing 1% SFN extract with 0.5% myrosinase) and 16 patients to the placebo group (1 sachet/day of 2.5 g containing corn starch colored with chlorophyll) for 2 months. After a washout period of 2 months, the groups were switched. NRF2 and NF-κB mRNA expression was evaluated by real-time quantitative polymerase chain reaction, and tumor necrosis factor alpha and interleukin-6 levels were quantified by enzyme-linked immunosorbent assay. Malondialdehyde was evaluated as a marker of lipid peroxidation. RESULTS: Twenty-five patients (17 women, 55 [interquartile range = 19] years and 55 [interquartile range = 74] months on HD) completed the study. There was no significant difference concerning the expression of mRNA NRF2 (P = .915) and mRNA NF-κB (P = .806) after supplementation with SFN. There was no difference in pro-inflammatory and oxidative stress biomarkers. CONCLUSION: 150 μmol of SFN for 2 months had no antioxidant and anti-inflammatory effect in patients with CKD undergoing HD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BRenal Insufficiency, ChronicSulfoxidesIsothiocyanatesHumansFemaleNF-E2-Related Factor 2Cross-Over StudiesOxidative StressRenal DialysisRNA, MessengerDietary Supplements

Stichwörter der Autor:innen

NF-kBNRF2chronic kidney diseaseinflammationsulforaphane

Substanzen

NF-kappa BsulforaphaneNF-E2-Related Factor 2RNA, MessengerSulfoxidesIsothiocyanates

Autor:innen und Institutionen

  • Graduate Program in Biological Sciences, Department of Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Graduate Program in Cardiovascular Sciences, Federal University Fluminense (UFF), Niterói, RJ, Brazil.
  • Graduate Program in Medical Sciences, Fluminense Federal University (UFF), Niterói, RJ, Brazil.
  • Graduate Program in Biological Sciences, Department of Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil; Graduate Program in Medical Sciences, Fluminense Federal University (UFF), Nite…
  • Federal University of Parana (UFPR), Department of Basic Pathology, Curitiba, Brazil.
  • Department of Nephrology, Centre Hopitalier Lyon Sud, INSERM 1060, CENS, Université de Lyon, France.

Zitieren

APA

Ribeiro, M., Cardozo, L. F., Paiva, B. R., Baptista, B. G., Fanton, S., Alvarenga, L., Lima, L. S., Britto, I., Nakao, L. S., Fouque, D., Ribeiro-Alves, M., & Mafra, D. (2024). Sulforaphane Supplementation Did Not Modulate NRF2 and NF-kB mRNA Expressions in Hemodialysis Patients. Journal of Renal Nutrition, 34(1), 68-75. https://doi.org/10.1053/j.jrn.2023.08.008

Vancouver

Ribeiro M, Cardozo LF, Paiva BR, Baptista BG, Fanton S, Alvarenga L, et al. Sulforaphane Supplementation Did Not Modulate NRF2 and NF-kB mRNA Expressions in Hemodialysis Patients. Journal of Renal Nutrition. 2024;34(1):68-75. doi:10.1053/j.jrn.2023.08.008

BibTeX
@article{Ribeiro2024,
  author = {Ribeiro, Marcia and Cardozo, Ludmila Fmf and Paiva, Bruna R and Baptista, Beatriz Germer and Fanton, Susane and Alvarenga, Livia and Lima, Ligia Soares and Britto, Isadora and Nakao, Lia S and Fouque, Denis and Ribeiro-Alves, Marcelo and Mafra, Denise},
  title = {Sulforaphane Supplementation Did Not Modulate NRF2 and NF-kB mRNA Expressions in Hemodialysis Patients},
  journal = {Journal of Renal Nutrition},
  year = {2024},
  volume = {34},
  number = {1},
  pages = {68--75},
  doi = {10.1053/j.jrn.2023.08.008}
}
Kostenlos starten →